Engleman EG - Search Results

1

Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease.

Merad M, Hoffmann P, Ranheim E, Slaymaker S, Manz MG, Lira SA, Charo I, Cook DN, Weissman IL, Strober S, Engleman EG. Merad M, et al. Among authors: engleman eg. Nat Med. 2004 May;10(5):510-7. doi: 10.1038/nm1038. Epub 2004 Apr 18. Nat Med. 2004. PMID: 15098028 Free PMC article.

2

Langerhans cells renew in the skin throughout life under steady-state conditions.

Merad M, Manz MG, Karsunky H, Wagers A, Peters W, Charo I, Weissman IL, Cyster JG, Engleman EG. Merad M, et al. Among authors: engleman eg. Nat Immunol. 2002 Dec;3(12):1135-41. doi: 10.1038/ni852. Epub 2002 Nov 4. Nat Immunol. 2002. PMID: 12415265 Free PMC article.

3

Induction of potent antitumor immunity by in situ targeting of intratumoral DCs.

Furumoto K, Soares L, Engleman EG, Merad M. Furumoto K, et al. Among authors: engleman eg. J Clin Invest. 2004 Mar;113(5):774-83. doi: 10.1172/JCI19762. J Clin Invest. 2004. PMID: 14991076 Free PMC article.

4

Developmental origin of interferon-alpha-producing dendritic cells from hematopoietic precursors.

Karsunky H, Merad M, Mende I, Manz MG, Engleman EG, Weissman IL. Karsunky H, et al. Among authors: engleman eg. Exp Hematol. 2005 Feb;33(2):173-81. doi: 10.1016/j.exphem.2004.10.010. Exp Hematol. 2005. PMID: 15676211 Free article.

5

Flk2+ myeloid progenitors are the main source of Langerhans cells.

Mende I, Karsunky H, Weissman IL, Engleman EG, Merad M. Mende I, et al. Among authors: engleman eg. Blood. 2006 Feb 15;107(4):1383-90. doi: 10.1182/blood-2005-05-1878. Epub 2005 Nov 1. Blood. 2006. PMID: 16263793 Free PMC article.

6

Differentiation of myeloid dendritic cells into CD8alpha-positive dendritic cells in vivo.

Merad M, Fong L, Bogenberger J, Engleman EG. Merad M, et al. Among authors: engleman eg. Blood. 2000 Sep 1;96(5):1865-72. Blood. 2000. PMID: 10961888 Free article.

7

In vivo manipulation of dendritic cells to induce therapeutic immunity.

Merad M, Sugie T, Engleman EG, Fong L. Merad M, et al. Among authors: engleman eg. Blood. 2002 Mar 1;99(5):1676-82. doi: 10.1182/blood.v99.5.1676. Blood. 2002. PMID: 11861283 Free article.

8

In vivo manipulation of dendritic cells overcomes tolerance to unmodified tumor-associated self antigens and induces potent antitumor immunity.

Okano F, Merad M, Furumoto K, Engleman EG. Okano F, et al. Among authors: engleman eg. J Immunol. 2005 Mar 1;174(5):2645-52. doi: 10.4049/jimmunol.174.5.2645. J Immunol. 2005. PMID: 15728471

9

Tolerance and chimerism after renal and hematopoietic-cell transplantation.

Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, Shizuru JA, Hoppe RT, Lowsky R, Engleman EG, Strober S. Scandling JD, et al. Among authors: engleman eg. N Engl J Med. 2008 Jan 24;358(4):362-8. doi: 10.1056/NEJMoa074191. N Engl J Med. 2008. PMID: 18216356 Free article.

10

Tolerogenic interactions between CD8⁺ dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts.

Hongo D, Tang X, Zhang X, Engleman EG, Strober S. Hongo D, et al. Among authors: engleman eg. Blood. 2017 Mar 23;129(12):1718-1728. doi: 10.1182/blood-2016-07-723015. Epub 2017 Jan 17. Blood. 2017. PMID: 28096089 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page